We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Long-Standing Distribution Agreement Between Instrumentation Laboratory and Beckman Coulter Comes to an End

By LabMedica International staff writers
Posted on 07 Jun 2012
Print article
After over 20 years of successful collaboration, Instrumentation Laboratory (Bedford, MA, USA) announced that their Strategic Alliance Cross-Distribution agreement with Beckman Coulter, Inc. (Brea, CA, USA) over their Hemostasis product line will terminate June 22, 2012.

Instrumentation Laboratory, a worldwide developer, manufacturer, and distributor of in vitro diagnostic instruments, related reagents, and controls, will end their distribution partnership with Beckman Coulter, a provider of instrument systems and products for life science. Beginning June 23, 2012, Instrumentation Laboratory will initiate direct sale and support services in the USA and Canada for their own Hemostasis product line in order to improve the quality of their products and services and simplify lab operations.

A strong focus on quality is precisely what has led to Instrumentation Laboratory’s success among hospitals and independent clinical laboratories worldwide, explained Ramon Benet, CEO, Instrumentation Laboratory, who is optimistic about the transition.

“[Instrumentation Laboratory] has achieved significant growth in Hemostasis, culminating in the attainment of the number one market share position worldwide, thanks to our focus on quality and innovation,” said Mr. Benet. “Now is the ideal time for us to apply our expertise, resources, and world-class service organization to working directly with our Hemostasis customers in North America, and focus on ensuring a smooth transition for our customers.”

Instrumentation Laboratories is currently the number one manufacturer of instruments and reagents for the Hemostasis market worldwide. Since the introduction of the first fully automated Hemostasis analyzer in 1985, the ACL 810, the company has continuously introduced innovative hospital and specialty lab products, culminating in the release of the ACL TOP Family of Hemostasis Testing Systems.

Along with Hemostasis systems, Instrumentation Laboratory’s product lines also include Critical Care and information management systems.



Related Links:

Instrumentation Laboratory

Beckman Coulter

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: The new blood test identifies key biomarkers of osteoarthritis (Photo courtesy of Shutterstock)

Blood Test Predicts Knee Osteoarthritis Eight Years Before Signs Appears On X-Rays

Osteoarthritis (OA) is the most prevalent form of arthritis, impacting millions worldwide and resulting in significant economic and social costs. Although no cure exists currently, the effectiveness of... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: The Sampler device could revolutionize sample collection for diagnostic tests (Photo courtesy of ReadyGo Diagnostics)

First of Its Kind Universal Tool to Revolutionize Sample Collection for Diagnostic Tests

The COVID pandemic has dramatically reshaped the perception of diagnostics. Post the pandemic, a groundbreaking device that combines sample collection and processing into a single, easy-to-use disposable... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.